{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:30:35Z","timestamp":1773210635776,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.vaccine.2007.10.028","type":"journal-article","created":{"date-parts":[[2007,11,6]],"date-time":"2007-11-06T12:20:25Z","timestamp":1194351625000},"page":"8771-8781","source":"Crossref","is-referenced-by-count":24,"title":["Non-coding pDNA bearing immunostimulatory sequences co-entrapped with leishmanial antigens in cationic liposomes elicits almost complete protection against experimental visceral leishmaniasis in BALB\/c mice"],"prefix":"10.1016","volume":"25","author":[{"given":"Saumyabrata","family":"Mazumder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Ravindran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antara","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahid","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2007.10.028_bib1","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/ije\/25.4.862","article-title":"The epidemic of visceral leishmaniasis in Western Upper Nile, Southern Sudan: course and impact from 1984 to 1994","volume":"25","author":"Seaman","year":"1996","journal-title":"Int J Epidemiol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.10.028_bib2","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1128\/IAI.68.10.5595-5602.2000","article-title":"Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library","volume":"68","author":"Melby","year":"2000","journal-title":"Infect Immun"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2007.10.028_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1179\/000349803225002561","article-title":"The pathogenesis of Leishmania\/HIV co-infection: cellular and immunological mechanisms","author":"Olivier","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2007.10.028_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1179\/000349803225002570","article-title":"Visceral leishmaniasis with those infected with HIV: clinical aspects and other opportunistic infections","volume":"97","author":"Russo","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"issue":"11","key":"10.1016\/j.vaccine.2007.10.028_bib5","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar","year":"2001","journal-title":"Trop Med Int Health"},{"issue":"6","key":"10.1016\/j.vaccine.2007.10.028_bib6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2174\/1566524043360212","article-title":"Progress in vaccine research and possible effector mechanisms in visceral leishmaniasis","volume":"4","author":"Ravindran","year":"2004","journal-title":"Curr Mol Med"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2007.10.028_bib7","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1017\/S0031182006001831","article-title":"Leishmania vaccines: progress and problems","volume":"133","author":"Kedzierski","year":"2006","journal-title":"Parasitology"},{"issue":"3","key":"10.1016\/j.vaccine.2007.10.028_bib8","first-page":"423","article-title":"Leishmaniasis vaccine candidates for development: a global overview","volume":"123","author":"Khamesipour","year":"2006","journal-title":"Indian J Med Res"},{"issue":"12","key":"10.1016\/j.vaccine.2007.10.028_bib9","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.4049\/jimmunol.167.12.6967","article-title":"Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease","volume":"167","author":"Uzonna","year":"2001","journal-title":"J Immunol"},{"issue":"6915","key":"10.1016\/j.vaccine.2007.10.028_bib10","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature01152","article-title":"CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity","volume":"420","author":"Belkaid","year":"2002","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.vaccine.2007.10.028_bib11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0952-7915(00)00118-7","article-title":"DNA vaccines: a key for inducing long-term cellular immunity","volume":"12","author":"Gurunathan","year":"2000","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.028_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jcb.20775","article-title":"DNA vaccines: successes and limitations in cancer and infectious disease","volume":"98","author":"Lowe","year":"2006","journal-title":"J Cell Biochem"},{"issue":"9115","key":"10.1016\/j.vaccine.2007.10.028_bib13","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(98)09552-X","article-title":"Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran","volume":"351","author":"Sharifi","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2007.10.028_bib14","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1086\/515265","article-title":"Field trial of a vaccine against New World cutaneous leishmaniasis in an at-risk child population: safety, immunogenicity, and efficacy during the first 12 months of follow-up","volume":"177","author":"Armijos","year":"1998","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2007.10.028_bib15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0264-410X(98)00220-5","article-title":"A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran","volume":"17","author":"Momeni","year":"1999","journal-title":"Vaccine"},{"issue":"6522","key":"10.1016\/j.vaccine.2007.10.028_bib16","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"issue":"5273","key":"10.1016\/j.vaccine.2007.10.028_bib17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1126\/science.273.5273.352","article-title":"Immunostimulatory DNA sequences necessary for effective intradermal gene immunization","volume":"273","author":"Sato","year":"1996","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2007.10.028_bib18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nri1329","article-title":"Immunotherapeutic uses of CpG oligodeoxynucleotides","volume":"4","author":"Klinman","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2007.10.028_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/08830180600743057","article-title":"Adjuvant activity of CpG oligodeoxynucleotides","volume":"25","author":"Klinman","year":"2006","journal-title":"Int Rev Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.10.028_bib20","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/eji.1830270712","article-title":"Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor alpha-mediated shock","volume":"27","author":"Sparwasser","year":"1997","journal-title":"Eur J Immunol"},{"issue":"16","key":"10.1016\/j.vaccine.2007.10.028_bib21","doi-asserted-by":"crossref","first-page":"9305","DOI":"10.1073\/pnas.96.16.9305","article-title":"CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells","volume":"96","author":"Hartmann","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.vaccine.2007.10.028_bib22","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1073\/pnas.93.7.2879","article-title":"CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma","volume":"93","author":"Klinman","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.vaccine.2007.10.028_bib23","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.4049\/jimmunol.156.12.4570","article-title":"Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides","volume":"156","author":"Cowdery","year":"1996","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2007.10.028_bib24","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.4049\/jimmunol.148.12.4072","article-title":"Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity","volume":"148","author":"Yamamoto","year":"1992","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.10.028_bib25","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4049\/jimmunol.157.5.1840","article-title":"Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA","volume":"157","author":"Ballas","year":"1996","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2007.10.028_bib26","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.20020147","article-title":"Vacccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against Leishmania major infection","volume":"195","author":"Rhee","year":"2002","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2007.10.028_bib27","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.4049\/jimmunol.168.3.1212","article-title":"CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide","volume":"168","author":"Miconnet","year":"2002","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.10.028_bib28","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1128\/IAI.73.9.5842-5852.2005","article-title":"Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL\/6 mice but does not prevent progressive disease in BALB\/c mice","volume":"73","author":"Iborra","year":"2005","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2007.10.028_bib29","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm0897-849","article-title":"Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants","volume":"3","author":"Roman","year":"1997","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.vaccine.2007.10.028_bib30","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/eji.200323614","article-title":"Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides","volume":"33","author":"Zelenay","year":"2003","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.10.028_bib31","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.4049\/jimmunol.157.5.2116","article-title":"Macrophages ingest and are activated by bacterial DNA","volume":"157","author":"Stacey","year":"1996","journal-title":"J Immunol"},{"issue":"Suppl. 5","key":"10.1016\/j.vaccine.2007.10.028_bib32","doi-asserted-by":"crossref","first-page":"B1","DOI":"10.1016\/S0264-410X(02)00514-5","article-title":"A role for liposomes in genetic vaccination","volume":"20","author":"Gregoriadis","year":"2002","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2007.10.028_bib33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.copbio.2004.10.005","article-title":"Liposomes virosomes as delivery systems for antigens, nucleic acids and drugs","volume":"15","author":"Felnerova","year":"2004","journal-title":"Curr Opin Biotechnol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.028_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/104454904322759911","article-title":"Evaluation of genetic immunization adjuvants to improve the effectiveness of a human immunodeficiency virus type 2 (HIV-2) envelope DNA vaccine","volume":"23","author":"Locher","year":"2004","journal-title":"DNA Cell Biol"},{"issue":"6741","key":"10.1016\/j.vaccine.2007.10.028_bib35","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/22326","article-title":"Therapy of tuberculosis in mice by DNA vaccination","volume":"400","author":"Lowrie","year":"1999","journal-title":"Nature"},{"issue":"35","key":"10.1016\/j.vaccine.2007.10.028_bib36","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1016\/j.vaccine.2007.05.042","article-title":"Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response","volume":"25","author":"Bhowmick","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2007.10.028_bib37","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/IAI.65.6.2371-2377.1997","article-title":"Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes","volume":"65","author":"Afrin","year":"1997","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2007.10.028_bib38","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1128\/IAI.70.12.6697-6706.2002","article-title":"Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB\/c mice","volume":"70","author":"Afrin","year":"2002","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.028_bib39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2007.10.028_bib40","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0264-410X(98)00383-1","article-title":"Immunoadjuvant action of plasmid DNA in liposomes","volume":"17","author":"Gursel","year":"1999","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.10.028_bib41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1550-7408.1958.tb02565.x","article-title":"An eight day method for screening compounds against Leishmania donovani in the golden hamster","volume":"5","author":"Stauber","year":"1958","journal-title":"J Protozool"},{"issue":"5","key":"10.1016\/j.vaccine.2007.10.028_bib42","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","article-title":"A limiting dilution assay for quantifying Leishmania major in tissues of infected mice","volume":"7","author":"Titus","year":"1985","journal-title":"Parasite Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.028_bib43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0966-842X(97)01145-1","article-title":"The role of CpG dinucleotides in DNA vaccines","volume":"6","author":"Krieg","year":"1998","journal-title":"Trends Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.10.028_bib44","first-page":"11","article-title":"Cationic liposome and plasmid DNA complexes formed in serum-free medium under optimum transfection condition are negatively charged","volume":"1466","author":"Son","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.vaccine.2007.10.028_bib45","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ymthe.2005.04.008","article-title":"Type I interferons potently suppress gene expression following gene delivery using liposome-DNA complexes","volume":"12","author":"Sellins","year":"2005","journal-title":"Mol Ther"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2007.10.028_bib46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-5793(96)01507-4","article-title":"Liposome-mediated DNA vaccination","volume":"402","author":"Gregoriadis","year":"1997","journal-title":"FEBS Lett"},{"issue":"9","key":"10.1016\/j.vaccine.2007.10.028_bib47","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1517\/14712598.4.9.1505","article-title":"Recent advances in vaccines for leishmaniasis","volume":"4","author":"Requena","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.028_bib48","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1128\/IAI.71.1.401-410.2003","article-title":"Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis","volume":"71","author":"Ahmed","year":"2003","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2007.10.028_bib49","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.exppara.2005.11.005","article-title":"Leishmania major: species specific delayed hypersensitivity reaction induced by exogenous secreted antigen in the guinea pig","volume":"112","author":"Khabiri","year":"2006","journal-title":"Exp Parasitol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.10.028_bib50","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0167-5699(91)90035-R","article-title":"Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis","volume":"12","author":"Dannenberg","year":"1991","journal-title":"Immunol Today"},{"issue":"3","key":"10.1016\/j.vaccine.2007.10.028_bib51","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.4049\/jimmunol.133.3.1594","article-title":"Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity","volume":"133","author":"Titus","year":"1984","journal-title":"J Immunol"},{"issue":"24","key":"10.1016\/j.vaccine.2007.10.028_bib52","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1073\/pnas.90.24.11473","article-title":"Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the Leishmania surface proteinase gp63","volume":"90","author":"Connell","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.10.028_bib53","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.iy.10.040192.002125","article-title":"Regulation of immunity to parasites by T cells and T cell-derived cytokines","volume":"10","author":"Sher","year":"1992","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.10.028_bib54","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1086\/315890","article-title":"Interleukin-12 regulates the response to chemotherapy in experimental visceral Leishmaniasis","volume":"182","author":"Murray","year":"2000","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2007.10.028_bib55","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.4049\/jimmunol.143.12.4244","article-title":"Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response","volume":"143","author":"Squires","year":"1989","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2007.10.028_bib56","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/IAI.69.8.4719-4725.2001","article-title":"Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis","volume":"69","author":"Melby","year":"2001","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2007.10.028_bib57","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.4049\/jimmunol.165.12.7064","article-title":"Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis","volume":"165","author":"Stager","year":"2000","journal-title":"J Immunol"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2007.10.028_bib58","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.vaccine.2003.09.030","article-title":"A mixed Th1\/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB\/c mice","volume":"22","author":"Mazumdar","year":"2004","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2007.10.028_bib59","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jgm.910","article-title":"Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration","volume":"8","author":"Hattori","year":"2006","journal-title":"J Gene Med"},{"issue":"6","key":"10.1016\/j.vaccine.2007.10.028_bib60","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.4049\/jimmunol.167.6.3324","article-title":"Sterically stabilized cationic liposomes improve the uptake and immunostimulatory activity of CpG oligonucleotides","volume":"167","author":"Gursel","year":"2001","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.028_bib61","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF03179837","article-title":"Improvement of DNA transfection with cationic liposomes","volume":"58","author":"Rocha","year":"2002","journal-title":"J Physiol Biochem"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.028_bib62","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2567.2004.01938.x","article-title":"TLR9\u2212\/\u2212 and TLR9+\/+ mice display similar immune responses to a DNA vaccine","volume":"113","author":"Babiuk","year":"2004","journal-title":"Immunology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07011978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07011978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T16:40:54Z","timestamp":1684082454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07011978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":62,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0264410X07011978"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.10.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}